Trials / Recruiting
RecruitingNCT05820802
High Dimensional Analysis of Immune Cells in Pediatric Patients
High Dimensional Analysis of Immune Cells Using scRNA-seq in Pediatric Patients With Allergic Reactions to Neuromuscular Blockers
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 294 (estimated)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 2 Years – 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to characterize immune cells using single-cell transcriptomic analysis in pediatric patients aged 2 to 18 years undergoing general anesthesia who are expected to receive Rocuronium, a non-depolarizing neuromuscular blocking agent, in the event of an allergic reaction.
Conditions
Timeline
- Start date
- 2023-04-27
- Primary completion
- 2026-04-01
- Completion
- 2026-12-01
- First posted
- 2023-04-20
- Last updated
- 2024-11-29
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05820802. Inclusion in this directory is not an endorsement.